SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression.

New therapeutic strategies are now being developed against adenocarcinoma associated with erbB-2 amplification, particularly by inhibiting p185erbB-2 expression. Antisense oligodeoxynucleotides seem promising for this purpose as long as they are efficiently protected against degradation and targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Allal, C., Sixou, S., Kravtzoff, R., Soulet, N., Soula, G., Favre, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150199/
https://www.ncbi.nlm.nih.gov/pubmed/9652760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150199/
https://www.ncbi.nlm.nih.gov/pubmed/9652760

Ejemplares similares